Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016) [Phase 2]
Merck's Phase 2 trial MK-6024-016 evaluating alternate dosing in adults with metabolic dysfunction-associated steatotic liver disease and no…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: The Effects of Dihydromiricetin on MASLD [NA]
A clinical trial evaluating Dihydromiricetin for nonalcoholic fatty liver disease (MASLD) has completed, according to ClinicalTrials.gov, sp…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease [Phase 2]
A Phase 2 clinical trial is evaluating aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) [Phase 4]
Phase 4 clinical trial evaluating a digital diet and exercise program to reduce liver fibrosis in Metabolic Dysfunction-Associated Steatotic…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy
A completed single-cell profiling study of liver-infiltrating immune cells in hepatocellular carcinoma associated with MASLD or hepatitis C …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Risk of MASLD in Adults in Romania
A completed clinical trial conducted in Romania evaluated risk factors for Metabolic dysfunction-associated steatotic liver disease (MASLD) …
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Antidiabetic Drugs for Steatotic Liver Disease [Phase 4]
Phase 4 clinical trial update evaluating antidiabetic drugs for steatotic liver disease (MASLD) and type 2 diabetes; the study has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
A clinical trial evaluating prognostic factors for hepatocellular carcinoma and liver transplantation in patients with MASLD/MASH; recruitme…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM [Phase 4]
Phase 4 clinical trial update evaluating henagliflozin for liver fibrosis in patients with MASLD and type 2 diabetes; the study is currently…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study of TVB-2640 in MASLD/MASH/NASH has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women [NA]
The document outlines a clinical trial evaluating whether live-streamed exercise improves liver health in pregnant women with MASLD, current…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism [NA]
A clinical trial evaluated intermittent calorie restriction in MASLD patients with abnormal glucose metabolism; results were posted in Septe…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
This clinical trial evaluated ultrasound-derived fat fraction as a means to assess metabolic dysfunction-associated steatotic liver disease …
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption [NA]
Completed clinical trial update evaluating the biological activity of serum enriched after TOTUM-448 consumption, in the context of NAFLD an…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)
The study evaluated Alpha-Glutathione-S-Transferase (AlphaGST) and the MARINA Index in metabolic dysfunction-associated steatotic liver dise…